Double Blind Pragmatic Randomised Controlled Trial (BOAT)
key details
| Value | £300,000 |
|---|---|
| Status | complete |
| Category (CPV) | 33600000 |
| Region | North East |
| Deadline | 24 Jun 2024 |
| Procedure | open |
| OCID | ocds-h6vhtk-046e40 |
Awards (2)
This procurement was awarded to 1 suppliers. Values shown are per-award; the notice total is £300,000.
| Supplier | Value | Date | Status |
|---|---|---|---|
| Eramol (UK) Ltd | £312,355 | 19 Sept 2024 | active |
| Eramol (UK) Ltd | · | · | active |
description
The Newcastle Upon Tyne NHS Foundation Trust has awarded a contract for the Provision of a Double Blind Pragmatic Randomised Controlled Trial: Bronchiectasis Optimising Azithromycin prevention Treatment to reduce exacerbations (BOAT) via open procedure to the supplier Eramol for 24 months with the option to extend for a further 12 months.
documents
- https://www.contractsfinder.service.gov.uk/Notice/08644d1b-df23-4cb5-85c0-428068107228 , tenderNotice
Documents are linked, not mirrored. They are served by the publishing authority and may require registration.
notice history
4 notices published against this procurement.
| Published | Type | Regime | Notice |
|---|---|---|---|
| 7 Jun 2024 | Contract notice (F02) | Earlier regulations | 017699-2024 |
| 7 Jun 2024 | Tender (tender) | · | 08644d1b-df23-4cb5-85c0-428068107228-757420 |
| 30 Oct 2024 | Contract award notice (F03) | Earlier regulations | 035124-2024 |
| 30 Oct 2024 | Award (award) | · | fe2df1fe-dd02-4db6-ac24-d7f08ee838e5-798310 |
more from The Newcastle Upon Tyne Hospitals NHS Foundation Trust
- Cardiology Insourcing · 23 Jul 2026
- Cellular Pathology · 23 Jul 2026
- Systemic Anti Cancer Therapy · 23 Jul 2026
- Paediatric Diabetes Network Support · 23 Jul 2026
- Laboratory Services Freeman Hospital · 23 Jul 2026
- Lab Services RVI - SQCL · 23 Jul 2026
- Breast Screening · 30 Jun 2026
- Stem Cell and Immunotherapy Services · 19 Jun 2026
all contracts from this buyer →
similar contracts awarded
Other awarded contracts in the same category. Useful for seeing who normally wins this kind of work, and at what value.
- Radiopharmaceutical Products - Poltech · The Christie NHS Foundation Trust · £39,000
- NHS Branded Medicines - Tranche B - London & South of England - 1 September 2026 · NHS England · £592,363,416
- NHS National Generics Pharmaceuticals - Supply Chain Resilience · NHS England · £52,447,296
- Generic, Branded Generic & Proprietary Medicinal Products - Group 18 · Regional Business Services Organisation, Procurement and Logistics Service · £1,800,000,000
- Generic Drugs – Injections/Infusions 2 · NHS Wales Shared Services Partnership-Procurement Services (hosted by Velindre University NHS Trust) · £6,535,850
- NP90726m Vedolizumab (Entyvio®) · The Common Services Agency (more commonly known as Public Services Delivery Scotland) (PSD Scotland)
- Transitional Drugs 7 · NHS Wales Shared Services Partnership-Procurement Services (hosted by Velindre University NHS Trust) · £53,566,932
- Combined Needles and Syringes Lot 1 · Secretary of State for Health and Social Care acting as part of the Crown through UK Health Security Agency · £15,264,000
source
Published on Contracts Finder. Contact details for named individuals are not reproduced on this site.